Medical Properties Trust Inc. (NYSE:MPW) has a beta of 0.56, a 12-month trailing P/E ratio of 23.74. The stock’s Relative Strength Index (RSI) is 61.99, with weekly volatility at 1.78% and ATR at 0.50. The MPW stock’s 52-week price range has touched low of $12.35 and a $24.29 high. Its shares traded lower over the last trading session, losing -0.53% on 12/10/20. The shares fell to a low of $20.20 before closing at $20.49. Intraday shares traded counted 4.2 million, which was -13.95% lower than its 30-day average trading volume of 3.69M. MPW’s previous close was $20.60 while the outstanding shares total 531.10M.
Investors have identified the REIT – Healthcare Facilities company Medical Properties Trust Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $10.69 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Medical Properties Trust Inc. (MPW) Fundamentals that are to be considered.
MPW were able to record 399.99 million as free cash flow during the Q3 2020 quarter of the year, this saw their quarterly net cash flow reduce by -1.28 billion. In cash movements, the company had a total of 442.22 million as operating cash flow.
Potential earnings growth for Medical Properties Trust Inc. (MPW)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the Q3 2020 quarter of the year, Medical Properties Trust Inc. recorded a total of 329.46 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 31.78% coming in sequential stages and their sales for the Q3 2020 quarter increasing by 11.42%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 189.54 million trying to sell their products during the last quarter, with the result yielding a gross income of 139.91 million. This allows shareholders to hold on to 531.10M with the recently reported earning now reading 0.25 cents per share. This is a figure that compared to analyst’s prediction for their Q3 2020 (0.41 cents a share).
Having a look at the company’s valuation, the company is expected to record 1.68 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on MPW sounds very interesting.
Is the stock of MPW attractive?
In related news, Director, Stewart Michael G sold 6,300 shares of the company’s stock in a transaction that recorded on Nov 04. The sale was performed at an average price of 19.11, for a total value of 120,393. As the sale deal closes, the VP, Controller & CAO, Hanna James Kevin now sold 17,500 shares of the company’s stock, valued at 350,350. Also, Chairman, President & CEO, Aldag Edward K JR sold 244,406 shares of the company’s stock in a deal that was recorded on Jul 08. The shares were price at an average price of 18.43 per share, with a total market value of 4,504,403. Following this completion of acquisition, the Chairman, President & CEO, Aldag Edward K JR now holds 156,569 shares of the company’s stock, valued at 2,912,183. In the last 6 months, insiders have changed their ownership in shares of company stock by 1.20%.
10 out of 12 analysts covering the stock have rated it a Buy, while 2 have maintained a Hold recommendation on Medical Properties Trust Inc.. 0 analysts has assigned a Sell rating on the MPW stock. The 12-month mean consensus price target for the company’s shares has been set at $21.71.